FDA label
What is Lumryz used for?
Lumryz contains sodium oxybate. The FDA-approved uses below are quoted from the Indications and Usage section of its DailyMed label.
Source: DailyMed SPL label file dated 2026-10-23. Publisher page
The FDA label says: “LUMRYZ is indicated for the treatment of cataplexy or excessive daytime sleepiness (EDS) in patients 7 years of age and older with narcolepsy.”
Run it in Rivvi
Which 2027 plans near you dropped or restricted Lumryz?
Tier changes and new prior auth, step therapy or quantity limits, plan by plan.
Free to start. Opens Rivvi, the AI workspace for healthcare teams.
Lumryz, for suspension, extended release
Indications and Usage, quoted from the label by Alkermes, Inc. (NDA214755). Cross-references to other label sections are left out.
LUMRYZ is indicated for the treatment of cataplexy or excessive daytime sleepiness (EDS) in patients 7 years of age and older with narcolepsy.
Source: DailyMed label, set id 10e5e40c-52f3-4c73-8a34-2c29c690a934, version 11, effective September 8, 2026. NDC 13551-001, one of 4 listings for this product.
Questions
What is Lumryz used for?
The FDA label says: “LUMRYZ is indicated for the treatment of cataplexy or excessive daytime sleepiness (EDS) in patients 7 years of age and older with narcolepsy.”
What drug class is Lumryz?
FDA lists sodium oxybate in the Central Nervous System Depressant established pharmacologic class.
Does this page cover off-label uses or dosing?
No. This page shows only the Indications and Usage section of the FDA label. Ask a pharmacist or prescriber about dosing.
More on Lumryz
- Is Lumryz a controlled substance?Schedule III
- Generic for LumryzFDA Orange Book
- What is Sodium Oxybate used for?FDA label uses
- Is Sodium Oxybate a controlled substance?Schedule III
- Generic for XyremFDA Orange Book
- Central Nervous System Depressants listFDA drug class
- NDC 13551-001Lumryz NDC record
- NDC 13551-002Lumryz NDC record
- NDC 13551-003Lumryz NDC record
- Schedule III drugs listDEA schedule